Enrofloxacin monohydrochloride
CAS: 93106-59-3
Ref. 3D-TDA10659
| 1g | Descontinuado | ||
| 5g | Descontinuado | ||
| 10g | Descontinuado | ||
| 25g | Descontinuado | ||
| 50g | Descontinuado | ||
| 250mg | Descontinuado | ||
| 2500mg | Descontinuado |
Informação sobre produto
Nome:
Enrofloxacin monohydrochloride
Sinónimos:
- 3-Quinolinecarboxylicacid, 1-cyclopropyl-7-(4-ethyl-1-piperazinyl)-6-fluoro-1,4-dihydro-4-oxo-,monohydrochloride (9CI)
Descrição:
Enrofloxacin monohydrochloride is a medicinal product that acts as a protein kinase inhibitor. It has been shown to inhibit the growth of cancer cells, including leukemia cells, by inducing apoptosis and cell cycle arrest. Enrofloxacin monohydrochloride has been tested in Chinese hamster ovary cells and found to be effective in inhibiting tumor growth. This drug is excreted mainly through urine and has been shown to have anticancer properties due to its ability to inhibit protein kinases involved in cancer cell proliferation. Enrofloxacin monohydrochloride is a promising therapeutic option for the treatment of various types of cancer in humans.
Aviso:
Os nossos productos estão destinados exclusivamente para uso em laboratório. Para qualquer outra aplicação, por favor entre em contacto.
Marca:
Biosynth
Armazenamento a longo prazo:
Notas:
Propriedades químicas
Peso molecular:
395.9 g/mol
Fórmula:
C19H23ClFN3O3
Pureza:
Min. 95%
MDL:
Ponto de fusão:
Ponto de ebulição:
Ponto de inflamação:
Densidade:
Concentração:
EINECS:
Merck:
Código HS:
